Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade
T. Nathanson, A. Ahuja, A. Rubinsteyn, B. A. Aksoy, M. D. Hellmann, D. Miao, E. Van Allen, T. Merghoub, J. Wolchok, A. Snyder, J. Hammerbacher
The paper reanalyzes exome and RNA-Seq data from melanoma patients treated with CTLA-4 blockade to assess the predictive value of somatic mutation burden and neoepitope homology to pathogens.
bioRxiv · Nov 17, 2016Cancer Biology